MFSD2A and metabolic dysfunction-associated steatotic liver disease: Of relevance to NAFLD, these findings suggest that reductions in hepatic Mfsd2a expression or blood levels of LPC-18:1 and LPC-PUFA could contribute to susceptibility for the development of this disease.